While we get into long threads, sometimes relevant. Sometimes subtly related to Onc..
I personally like to give some commentary, leading in to " new".
Yes, Monday starts a new day, month & even start of Q2.
in simple terms, calendar related...lots new.
however , we are lacking in any news updates.
Could Thursdays 5%+ increase be a new trend, or just well needed price recovery?
The oppotunities have been discussed sideways, backwards & forwards.
Simple deduction. Onclystics biotech needs a significant business development deal to proceed with either or both of the in waiting phase 3 trials.
The opportunities? A license/ partership deal? Countless convolutions & options.
A complete buyout? My personal preference.
Prices from one billion & upwards of tens of billions have been thrown around.
Same answer. Yes there are many comparables, that have offered much less than Onc & bought out for $5billion++
In broad strokes reality, nothing has changed. Time has moved forward. The timing of a deal is long over due.
The good news, few appreciate: The longer bracelet runs, the better.
Yes it is painful sitting & waiting. However, not happening " yet" does not in any way shape validate it won't happen.
So we wait.
Back to Thursdays price spike. Not huge volume, not a huge spike. However 5% in one day, a nice lift leading into the long weekend.
monday?
profit taking, sell off? Or further positive direction.
The news flow pragmatically supports neither.
The T.A. Numbers & price history indicate huge upside potential. As always we will see.
I do have a challenge for all posting on here.
See if you go a whole week without random Ad hominem attacks.
There was a time when mutiple threads carried out. Discussing Pelareorep, .M.O.A, various trial results & oppotunities.
a pleasure to read & be educated.
The name calling, open ended attacks & random distractions have become beyond obvious. fYI, check the read count.
BTW red hearings about mangemet wages, bonuses or stock options? 100% irrelevant to getting Pela to market.
THAT btw is the end goal & will be the only true way to realize the proper shareholder value.
I wish everyone a safe & healthy week.
side note, yet another acquaintance of mine.
Recent MRI repoert. Mutiple myeloma. After 6 months of chemo ( standard of care, not Pelareorep),
mutiple bone lesions, unchanged, one new, & one progressed.
General comments from oncologists " while various options have changed, the general outcomes with mastetic cancer,very little change in past 15 years"
Cancer my SH friends is not always a death sentence. Our lead trial Pancreatice cancer, generally is.
Should Onc get Pela into a panc phase 3 with Roche & any success, that will be considered a blockbuster.
well worth waiting for.